BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25697374)

  • 61. A central dip in the macular pigment spatial profile is associated with age and smoking.
    Kirby ML; Beatty S; Loane E; Akkali MC; Connolly EE; Stack J; Nolan JM
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6722-8. PubMed ID: 20592234
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evidence of macular pigment in the central macula in albinism.
    Wolfson Y; Fletcher E; Strauss RW; Scholl HPN
    Exp Eye Res; 2016 Apr; 145():468-471. PubMed ID: 26474496
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Macular pigment assessment by motion photometry.
    Moreland JD
    Arch Biochem Biophys; 2004 Oct; 430(2):143-8. PubMed ID: 15369811
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Macular Pigment Optical Density Fluctuation as a Function of Pupillary Mydriasis: Methodological Considerations for Dual-Wavelength Autofluorescence.
    Loskutova E; Butler JS; Hernandez Martinez G; Flitcroft I; Loughman J
    Curr Eye Res; 2021 Apr; 46(4):532-538. PubMed ID: 32842779
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evidence of lower macular pigment optical density in chronic open angle glaucoma.
    Igras E; Loughman J; Ratzlaff M; O'Caoimh R; O'Brien C
    Br J Ophthalmol; 2013 Aug; 97(8):994-8. PubMed ID: 23686328
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In vivo macular pigment measurements: a comparison of resonance Raman spectroscopy and heterochromatic flicker photometry.
    Hogg RE; Anderson RS; Stevenson MR; Zlatkova MB; Chakravarthy U
    Br J Ophthalmol; 2007 Apr; 91(4):485-90. PubMed ID: 16825281
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reliability of a commercially available heterochromatic flicker photometer, the MPS2, for measuring the macular pigment optical density of a Japanese population.
    Obana A; Gohto Y; Moriyama T; Seto T; Sasano H; Okazaki S
    Jpn J Ophthalmol; 2018 Jul; 62(4):473-480. PubMed ID: 29594609
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Enhancing performance while avoiding damage: a contribution of macular pigment.
    Stringham JM; Snodderly DM
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6298-306. PubMed ID: 23982840
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A new desktop instrument for measuring macular pigment optical density based on a novel technique for setting flicker thresholds.
    van der Veen RL; Berendschot TT; Hendrikse F; Carden D; Makridaki M; Murray IJ
    Ophthalmic Physiol Opt; 2009 Mar; 29(2):127-37. PubMed ID: 19236582
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Macular pigment optical density and visual quality of life.
    Wilson MR; Sandberg KA; Foutch BK
    J Optom; 2021; 14(1):92-99. PubMed ID: 32868244
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Chromatic VEP assessment of human macular pigment: comparison with minimum motion and minimum flicker profiles.
    Robson AG; Holder GE; Moreland JD; Kulikowski JJ
    Vis Neurosci; 2006; 23(2):275-83. PubMed ID: 16638178
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification of Surrogate Biomarkers for the Prediction of Patients at Risk of Low Macular Pigment in Type 2 Diabetes.
    Scanlon G; McCartney D; Butler JS; Loskutova E; Loughman J
    Curr Eye Res; 2019 Dec; 44(12):1369-1380. PubMed ID: 31225969
    [No Abstract]   [Full Text] [Related]  

  • 73. The impact of macular pigment augmentation on visual performance using different carotenoid formulations.
    Loughman J; Nolan JM; Howard AN; Connolly E; Meagher K; Beatty S
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7871-80. PubMed ID: 23132800
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study.
    Trieschmann M; Beatty S; Nolan JM; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D
    Exp Eye Res; 2007 Apr; 84(4):718-28. PubMed ID: 17306793
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dosage-dependent reduction of macular pigment optical density in female breast cancer patients receiving tamoxifen adjuvant therapy.
    Lim IL; Loo AVP; Subrayan V; Khang TF; See MH; Alip A; Taib NAM
    Breast; 2018 Jun; 39():117-122. PubMed ID: 29660599
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Influence of macular pigment on the sensitivity to discomfort glare from daylight.
    Jain S; Wienold J; Eandi C; Gisselbaek S; Kawasaki A; Andersen M
    Sci Rep; 2023 Oct; 13(1):18551. PubMed ID: 37899478
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Concordance of Macular Pigment Measurement Using Customized Heterochromatic Flicker Photometry and Fundus Autofluorescence in Age-Related Macular Degeneration.
    Akuffo KO; Beatty S; Stack J; Peto T; Leung I; Corcoran L; Power R; Nolan JM
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8207-14. PubMed ID: 26720473
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Relationship between macular pigment and visual acuity in eyes with early age-related macular degeneration.
    Puell MC; Palomo-Alvarez C; Barrio AR; Gómez-Sanz FJ; Pérez-Carrasco MJ
    Acta Ophthalmol; 2013 Jun; 91(4):e298-303. PubMed ID: 23575039
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Apolipoprotein E genotype is associated with macular pigment optical density.
    Loane E; McKay GJ; Nolan JM; Beatty S
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2636-43. PubMed ID: 20107178
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Macular Pigment Optical Density in the Korean Population: a Cross Sectional Study.
    Hong IH; Jung WH; Lee JH; Chang IB
    J Korean Med Sci; 2020 Feb; 35(5):e30. PubMed ID: 32030919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.